RIVER EDGE, NJ, October 22, 2015 /Businesswire/ — Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, announced today that data about Nephros’ DSU-D ultrafilter will be presented in a poster at the American Society of Nephrology’s Kidney Week 2015 in San Diego, California.
Title: A Filter Placed Along the Path of the Water Treatment System Can Reduce Inflammation in Patients on Chronic Dialysis
Session: Standard Hemodialysis for ESRD – II
Date/Time: Friday, November 6, 2015 10:00 AM – 12:00 PM
Location: Exhibit Hall
The full abstract can be found via the following weblink: http://www.abstracts2view.com/asn_2015/view.php?nu=3916&terms=&type=abstract
About Nephros, Inc.
Nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters, as well as a hemodiafiltration system for the treatment of patients with end stage kidney disease. Its filters, which it calls ultrafilters, are used primarily in medical applications. Nephros ultrafilters are used by dialysis centers for the removal of biological contaminants from the water and bicarbonate concentrate feeding hemodialysis devices. Additionally, Nephros ultrafilters are used in hospitals and medical clinics as an aid in infection control by retaining bacteria (i.e. Legionella, Pseudomonas), virus and endotoxin from water used by patients.
For more information about Nephros, please visit the company’s website at www.nephros.com.
PCG Advisory Group
Kirin M. Smith, Chief Operating Officer
Click Here to view External Links